|
|
||||||||
REVIEW
1 Department of Internal Medicine and Veterans Affairs Medical Center, and
2 Interdisciplinary Immunology Program, University of Iowa, Iowa City, Iowa
nicholas-zavazava{at}uiowa.edu
The ongoing debate on human embryonic stem cells (hESC) is fuelled by ethical concerns but also by the legitimate hope that hESC could one day be used for the cure of presently untreatable human diseases. Here we discuss current approaches to and constraints upon hESC differentiation and describe their potential application in clinical medicine.
This article has been cited by other articles:
![]() |
K. K. Intemann and Inmaculada de Melo-Martin Regulating scientific research: should scientists be left alone? FASEB J, March 1, 2008; 22(3): 654 - 658. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |